Supplementary Tables 5-8 from Pembrolizumab and Paclitaxel in Patients with HR+/HER2− Breast Cancer with HER2-Enriched or Basal-like Subtypes
收藏数据链接：
官方服务：
资源简介：
Tables S5-8 showing results from univariate analysis for ORR, CBR, PFS and OS
创建时间：
2026-04-01
